Oracle Pain Clinic, INC.

Oracle Pain Clinic, INC. was paid $951K by Medicaid between Jan 2018 and Dec 2024, across 34 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 31% of everything it billed.

Compared with peers

Next to other Internal Medicine Physician providers in Ohio

Rank by total paid#55 of 663

Median peer was paid$17K

This provider vs. median55×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,382	$21K
2019	11,997	$125K
2020	13,558	$189K
2021	5,569	$168K
2022	5,245	$170K
2023	5,338	$152K
2024incomplete	4,120	$127K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	31%	2,481	2,385	$291K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	23%	10,835	9,326	$222K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	15%	4,459	4,028	$144K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	6.7%	1,110	1,036	$64K
80305		3.0%	4,222	3,995	$28K
80346		1.7%	916	834	$16K
80363		1.4%	915	833	$14K
80361		1.4%	925	843	$14K
80370		<1%	929	847	$8K
80355		<1%	930	848	$8K
80368		<1%	930	848	$8K
80366		<1%	930	848	$8K

22 more codes

80336		<1%	930	$8K
80373		<1%	929	$8K
80372		<1%	930	$8K
80324		<1%	916	$8K
80360		<1%	916	$8K
80359		<1%	916	$8K
80356		<1%	916	$8K
80345		<1%	915	$8K
80358		<1%	916	$8K
80353		<1%	916	$8K
80348		<1%	915	$8K
80354		<1%	916	$8K
80349		<1%	916	$8K
80365		<1%	893	$8K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	2,192	$6K
77002		<1%	211	$5K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	418	$3K
20610		<1%	120	$2K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	58	$2K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	1,641	$917.93
83992		<1%	80	$92.13
G9622	Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method	0%	67	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialESSANDOH, SAMUEL (PRESIDENT)